Cardiology Cases Wrap Up Flashcards
INR goal for pt w.o artificial valve (non-mechanical)
2.0-3.0
INR goal for pt w. artificial valve (mechanical)
2.5-3.5
when can you use the term “coumadin failure”
only if pt was on therapeutic dose when fail occurred
otherwise, it’s subtherapeutic fail
t/f: a single coumadin dose can affect INR
t!
need to know what dose pt was on when INR was obtained
best AC for severe renal dz or ESRD
warfarin
AC for pt w. mechanical valve
warfarin
2 cons of warfarin
narrow therapeutic index -> must check INR
many food/ddi
3 benefits of DOACs over warfarin
fewer interactions
less ICH/fatal bleeding
bridging not needed (rapid onset/offset)
4 cons of DOACs
expensive
some lack or have expensive reversal agents
higher rate of GIB
not approved in ESRD
warfarin has a higher rate of __ bleeds
DOACs have a higher rate of __ bleeds
warfarin: ICH/fatal
DOACs: GIB/non fatal
what are the 4 doac’s
dabigatran (pradaxa)
rivaroxaban (xarelto)
apixaban (eliquis)
edoxaban (savaysa)
dabigatran is a __ inhibitor, whereas the other 3 doac’s are __ inhibitors
dabigatran: direct thrombin
others: Xa
jaynstein’s go to doac
apixaban (eliquis)
CHADSVASC
afib rate control: strict vs lenient vs exertional
strict: < 80
lenient: < 110
exertional: < 115
options for chronic rate control in afib (2)
bb
ccb (non dihydropiridines -> diltiazem, verapamil)
2 conditions that digoxin is used for
HFrEF
afib
only for pt w. inadequate rate control w. bb and/or ccb
which ac’s have reversal agents
warfarin
dabigatran (pradaxa)
rivaroxaban (xarelto)
apixaban (eliquis)
edoxaban (savaysa)
reversal agent for dabigatran
praxbind
andexxa is the reversal agent for (3)
rivaroxaban (xarelto)
apixaban (eliquis)
edoxaban (savaysa)
5 s.e of hctz
hypo’s:
hyponatremia
hypokalemia
hypomagnesemia
hypochloremic alkalosis
plus hyperglycemia and hyperuricemia
caution w. hctz in what 2 conditions
gout
DM
which mucinex is contraindicated w. htn
mucinex d - the d is pseudoephedrine (can cause htn)
regular mucinex is ok
2 common s.e of norvasc (amlodipine)
peripheral edema
fatigue
bp goal for htn + dm
< 130/80
ideal classes of meds for htn + dm (3)
diuretics
acei/arb
ccb
what ccb are best for htn + dm
dihydropiridines (amlodipine/novasc)
life threatening s.e of amlodipine
angina/MI
hypotn
pulmonary edema
use amlodipine w. extreme caution in what 2 conditions
AS - can cause MI
CHF - can decrease afterload
ccb work best for htn for what patient population
AA
life threatening s.e of ACEI (6)
angioedema
cholestatic jaundice -> fulminant hepatic necrosis
hyperkalemia
ARF
hypotn
severe hypersensitivity
angioedema manifesting as abdominal pain may occur more often in what pt pop
AA
common s.e of ACEI (4)
hyperkalemia
elevated Cr
dizzy
cough
life threatening s.e of bb (4)
AV block
bradycardia
CNS dpn
hypotn
common s.e of bb (4)
hypotn
bradycardia
dizzy
worsen raynaud or peripheral vascular dz
life threatening s.e of hctz (2)
severe lyte disturbance
angle-closure glaucoma
common s.e of ARBs (3)
cough
hyperkalemia
elevated Cr
life threatening s.e of ARBs (4)
angioedema
hyperkalemia
hypotn
renal fxn decline
t/f: if a pt has a cough w. lisinopril, you should try losartan
t!
t/f: if a pt has angioedema w. lisinopril you should try losartan
hell no! why would you think you can do this you idiot?!
jk… i thought you could too
what class of drug is clonidine
alpha blocker
common s.e of clonidine (6)
xerostomia
drowsy
ha
fatigue
dizzy
transient skin rash
3 life threatening s.e of clonidine
bradycardia
cns dpn
hypotn
which ccb is extended release
diltiazem
4 common s.e of diltiazem
peripheral edema
ha
bradycardia
dizzy
4 life threatening s.e of diltiazem
av block
bradycardia
sjs
hypotn
moa of hydralazine
vasodilator
indication for hydralazine
acute htn episodes (usually inpt setting)
not really used for long term control
t/f: you should treat asymptomatic htn acutely in the op setting
f!
don’t do it
just address stricter control of long term meds
common s.e of hydralazine (6)
earache
tachy
palpitations
angina
n/v
diarrhea
3 life threatening s.e of hydralazine
lupus-like syndrome
blood dyscrasia
MI
2 contraindications for hydralazine
CAD
peripheral neuritis